NovaBay Pharmaceuticals, Inc. (NYSE American: NBY), to be renamed Stablecoin Development Corporation (NYSE American: SDEV), is an on-chain holding company focused on long-duration participation in protocol-aligned digital asset ecosystems. The Company's common stock is expected to begin trading on the NYSE American under the ticker symbol SDEV on April 3, 2026. In 2026, the Company completed a comprehensive realignment of its business, adopting a capital allocation approach focused on acquiring and holding economically productive digital assets that enable participation in open, decentralized financial networks. The Company's core business consists of the accumulation, holding, and deployment of operating digital assets for use within blockchain-based networks to support protocol-level services, including staking, governance participation, and related activities. The Company's initial focus is SKY, the protocol token of the decentralized Sky Protocol. In January 2026, the Company completed a ~$134 million private placement with R01 Fund LP, Framework Ventures, Tether Investments, and Sky Frontier Foundation, consisting of cash, stablecoins, and SKY tokens. The Company continues to deploy capital toward the acquisition of additional SKY tokens on the open market. Headquartered in Emeryville, California. Committed to prudent governance, regulatory compliance, and long-term shareholder value creation. For more information, visit www.novabay.com.
我们正在追踪 NovaBay Pharmaceuticals 的市场扩张
NovaBay Pharmaceuticals 的国际扩张与竞争对手的对比情况
NovaBay Pharmaceuticals你条形图显示所对比公司之间的相对规模。
列5| 公司 | 市场 | 新市场 | 势头 | 活动 | 扩张评分 |
|---|---|---|---|---|---|
 NovaBay Pharmaceuticals你 | 0 | 0 | — | 0 | 0 |
当前没有招聘
注册以跟踪该公司，并在发生变化时第一时间获得提醒。
没有进行中的营销活动
注册以跟踪该公司，并在发生变化时第一时间获得提醒。
解锁已验证邮箱与直拨电话
免费 · 无需信用卡
关于 NovaBay Pharmaceuticals 的业务、市场和增长信号的快速解答。
